Zobrazeno 1 - 10
of 325
pro vyhledávání: '"de Mey, C."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 53:247-255
BACKGROUND Flupirtine is a nonopioid, central analgesic without antipyretic or antiphlogistic properties. Flupirtine-MR is an oral modified-release formulation with a 100 mg fast-input and a 300 mg portion with slow protracted release. METHODS Single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff6c578a7f90b8d400009310a337e75
https://doi.org/10.5414/cp202236
https://doi.org/10.5414/cp202236
Publikováno v:
Arzneimittelforschung. 49:351-358
This multicenter, placebo-controlled, double-blind, randomized parallel-group trial was conducted to investigate the efficacy and tolerability of myrtol standardized (MYS, Gelomyrtol forte, 3 x 300 mg) in the long-term treatment of patients with chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9acd1c9418085dfb50172ee2744c39d1
https://doi.org/10.1055/s-0031-1300426
https://doi.org/10.1055/s-0031-1300426
Autor:
de Mey C
Publikováno v:
Current Medical Research and Opinion. 14:187-202
Erectile function in man depends upon a complex interaction of psychogenic, neurologic, hormonal and vascular factors, and therefore the management of erectile dysfunction (ED) reflects this complexity of control. Therapeutic options include psycholo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fbd380d50fe817dbe205768c6ecaa18
https://doi.org/10.1185/03007999809113359
https://doi.org/10.1185/03007999809113359
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical Pharmacology & Therapeutics, 70(2), 142-148. Nature Publishing Group
Objective. Our objective was to investigate the potential for relevant pharmacotherapeutic interaction between cytochrome P4503A4 (CYP3A4)-inhibiting agents such as erythromycin and the dopamine agonist alpha -dihydroergocryptine (DHEC). Methods. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e1379784b2e3272dcc0ce73ef96c734a
https://research.rug.nl/en/publications/658fcea6-d92b-4bcb-a3bd-1f408f7926e0
https://research.rug.nl/en/publications/658fcea6-d92b-4bcb-a3bd-1f408f7926e0
Autor:
De Mey C
Publikováno v:
European urology. 38
Randomised controlled trials (RCTs) provide the best available external evidence for the use of alpha1-blockers in treating lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO). Placebo-controlled and actively-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37dc62dc8e978be34b4845f74e8520c1
https://pubmed.ncbi.nlm.nih.gov/11111206
https://pubmed.ncbi.nlm.nih.gov/11111206
Publikováno v:
Europe PubMed Central
Red vine leaf extract (RVLE) is a herbal medicine containing several flavonoids, with quercetin-3-O-beta-glucuronide and isoquercitrin (quercetin-3-O-beta-glycoside) as the main components.To assess the efficacy and safety of once-daily doses of 360
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f346f9180cb9fa4e319441d9e93dc1da
https://pubmed.ncbi.nlm.nih.gov/10719612
https://pubmed.ncbi.nlm.nih.gov/10719612
Autor:
Siegel, G., Rodríguez, M., Sauer, F., Abletshauser, C., de Mey, C., Schötz, K., Ringstad, L., Malmsten, M., Schäfer, P.
Publikováno v:
In Biosensors and Bioelectronics 2009 24(5):1512-1517
Publikováno v:
Drug Research; 2016, Vol. 66 Issue 7, p384-392, 9p